These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tyrosine kinase receptors as attractive targets of cancer therapy. Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157 [TBL] [Abstract][Full Text] [Related]
7. Identification of receptor protein tyrosine phosphatases (RPTPs) as regulators of receptor tyrosine kinases (RTKs) using an RPTP siRNA-RTK substrate screen. Lee H; Bennett AM Methods Mol Biol; 2015; 1233():111-20. PubMed ID: 25319894 [TBL] [Abstract][Full Text] [Related]
8. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases. Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391 [TBL] [Abstract][Full Text] [Related]
9. A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling. Friedman A; Perrimon N Nature; 2006 Nov; 444(7116):230-4. PubMed ID: 17086199 [TBL] [Abstract][Full Text] [Related]
10. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Paulson RF; Vesely S; Siminovitch KA; Bernstein A Nat Genet; 1996 Jul; 13(3):309-15. PubMed ID: 8673130 [TBL] [Abstract][Full Text] [Related]
11. Receptor tyrosine kinases: from biology to pathology. Choura M; Rebaï A J Recept Signal Transduct Res; 2011 Dec; 31(6):387-94. PubMed ID: 22040163 [TBL] [Abstract][Full Text] [Related]
12. Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors. Peron M; Lovisa F; Poli E; Basso G; Bonvini P PLoS One; 2015; 10(7):e0132330. PubMed ID: 26147305 [TBL] [Abstract][Full Text] [Related]
13. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Müller-Tidow C; Diederichs S; Bulk E; Pohle T; Steffen B; Schwäble J; Plewka S; Thomas M; Metzger R; Schneider PM; Brandts CH; Berdel WE; Serve H Cancer Res; 2005 Mar; 65(5):1778-82. PubMed ID: 15753374 [TBL] [Abstract][Full Text] [Related]
14. Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies. Correll PH; Paulson RF; Wei X Gene; 2006 Jun; 374():26-38. PubMed ID: 16524673 [TBL] [Abstract][Full Text] [Related]
15. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases. Abella JV; Park M Am J Physiol Endocrinol Metab; 2009 May; 296(5):E973-84. PubMed ID: 19240253 [TBL] [Abstract][Full Text] [Related]
16. Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. van Biesen T; Hawes BE; Luttrell DK; Krueger KM; Touhara K; Porfiri E; Sakaue M; Luttrell LM; Lefkowitz RJ Nature; 1995 Aug; 376(6543):781-4. PubMed ID: 7651538 [TBL] [Abstract][Full Text] [Related]
17. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas. Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413 [TBL] [Abstract][Full Text] [Related]